An Overview of COVID-19 Medicines in Current Guidelines
An acute respiratory disease caused by a new coronavirus (Severe acute respirotary syndrome-coronavirüs-2, previously known as 2019-nCoV), coronavirus disease 2019 (COVID-19), appeared in December 2019 and then has spread rapidly throughout the world starting from China, Japan and South Korea. As of...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2020-12-01
|
| Series: | Bezmiâlem Science |
| Subjects: | |
| Online Access: |
http://bezmialemscience.org/archives/archive-detail/article-preview/an-overview-of-covd-19-medicines-in-current-guidel/42780
|
| _version_ | 1797907081027649536 |
|---|---|
| author | Mustafa GÖKÇE Eray Metin GÜLER |
| author_facet | Mustafa GÖKÇE Eray Metin GÜLER |
| author_sort | Mustafa GÖKÇE |
| collection | DOAJ |
| description | An acute respiratory disease caused by a new coronavirus (Severe acute respirotary syndrome-coronavirüs-2, previously known as 2019-nCoV), coronavirus disease 2019 (COVID-19), appeared in December 2019 and then has spread rapidly throughout the world starting from China, Japan and South Korea. As of January 30, 2020, the World Health Organization has officially declared the COVID-19 outbreak. Considering the clinical symptoms of COVID-19, it has many symptoms such as high fever, cough, and fatigue. It is reported that this disease is very severe and causes serious consequences such as cytokine storm and acute respiratory distress syndrome in the elderly and those with chronic diseases. Currently, scientists are trying to find a specific antiviral treatment strategy. Various medications such as hydroxychloroquine, lopinavir/ ritonavir, ribavirin, remdesivir and favipiravir are currently being applied in clinical trials to test their efficacy and safety worldwide in COVID-19 treatment, and some promising results have been achieved so far. In this review, agents with potential efficacy against COVID-19 are presented in summary. |
| first_indexed | 2024-04-10T10:30:48Z |
| format | Article |
| id | doaj.art-4b82b358443947349b6cda0b326f97f6 |
| institution | Directory Open Access Journal |
| issn | 2148-2373 2148-2373 |
| language | English |
| last_indexed | 2024-04-10T10:30:48Z |
| publishDate | 2020-12-01 |
| publisher | Galenos Publishing House |
| record_format | Article |
| series | Bezmiâlem Science |
| spelling | doaj.art-4b82b358443947349b6cda0b326f97f62023-02-15T16:21:07ZengGalenos Publishing HouseBezmiâlem Science2148-23732148-23732020-12-01839910410.14235/bas.galenos.2020.452213049054An Overview of COVID-19 Medicines in Current GuidelinesMustafa GÖKÇE0Eray Metin GÜLER1 Bezmialem Vakıf University Faculty of Pharmacy, Department of Pharmacology, İstanbul, Turkey Bezmialem Vakıf University Faculty of Medicine, Department of Medical Biochemistry, İstanbul, Turkey An acute respiratory disease caused by a new coronavirus (Severe acute respirotary syndrome-coronavirüs-2, previously known as 2019-nCoV), coronavirus disease 2019 (COVID-19), appeared in December 2019 and then has spread rapidly throughout the world starting from China, Japan and South Korea. As of January 30, 2020, the World Health Organization has officially declared the COVID-19 outbreak. Considering the clinical symptoms of COVID-19, it has many symptoms such as high fever, cough, and fatigue. It is reported that this disease is very severe and causes serious consequences such as cytokine storm and acute respiratory distress syndrome in the elderly and those with chronic diseases. Currently, scientists are trying to find a specific antiviral treatment strategy. Various medications such as hydroxychloroquine, lopinavir/ ritonavir, ribavirin, remdesivir and favipiravir are currently being applied in clinical trials to test their efficacy and safety worldwide in COVID-19 treatment, and some promising results have been achieved so far. In this review, agents with potential efficacy against COVID-19 are presented in summary. http://bezmialemscience.org/archives/archive-detail/article-preview/an-overview-of-covd-19-medicines-in-current-guidel/42780 covid-19antiviralstreatmentsars-cov-2 |
| spellingShingle | Mustafa GÖKÇE Eray Metin GÜLER An Overview of COVID-19 Medicines in Current Guidelines Bezmiâlem Science covid-19 antivirals treatment sars-cov-2 |
| title | An Overview of COVID-19 Medicines in Current Guidelines |
| title_full | An Overview of COVID-19 Medicines in Current Guidelines |
| title_fullStr | An Overview of COVID-19 Medicines in Current Guidelines |
| title_full_unstemmed | An Overview of COVID-19 Medicines in Current Guidelines |
| title_short | An Overview of COVID-19 Medicines in Current Guidelines |
| title_sort | overview of covid 19 medicines in current guidelines |
| topic | covid-19 antivirals treatment sars-cov-2 |
| url |
http://bezmialemscience.org/archives/archive-detail/article-preview/an-overview-of-covd-19-medicines-in-current-guidel/42780
|
| work_keys_str_mv | AT mustafagokce anoverviewofcovid19medicinesincurrentguidelines AT eraymetinguler anoverviewofcovid19medicinesincurrentguidelines AT mustafagokce overviewofcovid19medicinesincurrentguidelines AT eraymetinguler overviewofcovid19medicinesincurrentguidelines |